针对肝细胞癌的抗流体纳米疗法
Zhuo Yu1, Leaf Huang2, Jianfeng Guo3
1Department of Hepatopathy, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
概括
肝细胞癌 (HCC) 恶性恶性由瘤微环境 (TME) 流体恶化. 纳米药物输送系统为克服HCC治疗耐药性提供了有希望的抗风流疗法.
科学领域:
- 在瘤学瘤学.
- 纳米技术纳米技术
- 癌症生物学 癌症生物学
背景情况:
- 肝细胞癌 (HCC) 是一种主要的肝癌,是全球癌症死亡的主要原因.
- 瘤微环境 (TME) 层显著促进HCC的进展和治疗耐药性.
结论:
- 抗风暴纳米疗法显示出安全,有效和特定的HCC治疗的潜力.
- 准TME层是改善HCC治疗结果的有希望的策略.
更多相关视频
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
5.2K
11:08Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
778
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:15Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K